scroll
14 DAYS FREE ACCESS
Join Market Matters and get full access
to all our Opinion + Action
ASX.CSL $269.79
20 MINUTE DELAYED
ANALYSIS
OPINION
ACTION
more
i
PERFORMANCE
i
SHARE PRICE ACTIVITY | |
---|---|
Last (Price) | 269.79 |
Change | 0.00 (0.00) |
Bid / Ask | 0.00 - 0.00 |
Volume | 0 |
Volume (3mths avg) | 17,485,360 |
Turnover | 0 |
Open | 0.00 |
Day Range | 265.76 - 271.15 |
VWAP | 0.00 |
Prev Close | 269.79 |
Last Trade | 06.10 29/06 (AEST) |
i
KEY INFORMATION | |
---|---|
Sector | Healthcare |
Shares Issued | 454,807,152 |
NTA/Share | 42.34 |
Last Dividend | 1.42 |
Dividend Ex Date | 07 MAR 2022 |
Dividend Pay Date | 06 APR 2022 |
i
CURRENT (USD) | |
---|---|
Revenue | 10,310.00 |
EBITDA | 3,719.60 |
Profit | 2,375.00 |
Earnings Per Share (EPS) | 7.54 |
Dividend Per Share (DPS) | 3.18 |
Yield % | 1.12 |
Market Cap | 132,002.00 |
Price to Earnings Ratio (P/E) | 38.1 |
i
TARGET PRICE FORECAST
i
ESTIMATES (USD) | |
---|---|
Revenue | 10,707.86 |
EBITDA | 3,511.85 |
Profit | 2,296.93 |
Dividend Per Share (DPS) | 2.11 |
Earnings Per Share (EPS) | 4.94 |
i
BROKER CONSENSUS RECOMMENDATION
BUY
SELL
Target Price
0.00
Lt Growth Rate
0.00
Recommendation (BUY)
1.80
ACTION
CSL
UPDATED
22/03/2022 23:08
CSL
UPDATED
09/03/2022 16:33
MM are adding to CSL in the Flagship Growth Portfolio, increasing by 2% around $255.20
Add To Hit List
RMD
UPDATED
09/03/2022 16:32
MM is considering increasing our exposure to ResMed (RMD) and CSL Ltd (CSL)
Add To Hit List
CSL
UPDATED
16/02/2022 17:39
CSL
UPDATED
15/02/2022 17:52
CSL
UPDATED
04/02/2022 18:55
CSL
UPDATED
22/12/2021 17:09
CSL
UPDATED
16/12/2021 17:17
CSL
UPDATED
16/12/2021 08:26
CSL
UPDATED
14/12/2021 07:02
Business Summary
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL's operating model for its two businesses, CSL Behring and Seqirus.Relevant suggested news and content from the site
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.